Windlas Biotech Ltd
NSE:WINDLAS

Watchlist Manager
Windlas Biotech Ltd Logo
Windlas Biotech Ltd
NSE:WINDLAS
Watchlist
Price: 1 116 INR 9.83%
Market Cap: 23.2B INR
Have any thoughts about
Windlas Biotech Ltd?
Write Note

Gross Margin
Windlas Biotech Ltd

37.4%
Current
36%
Average
43.9%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.4%
=
Gross Profit
2.5B
/
Revenue
6.6B

Gross Margin Across Competitors

Country IN
Market Cap 23.2B INR
Gross Margin
37%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 208.7B USD
Gross Margin
41%
Country US
Market Cap 177.4B USD
Gross Margin
60%
Country KR
Market Cap 71.4T KRW
Gross Margin
50%
Country CH
Market Cap 38.8B CHF
Gross Margin
29%
Country US
Market Cap 37.5B USD
Gross Margin
35%
Country US
Market Cap 37.5B USD
Gross Margin
55%
Country US
Market Cap 27.4B USD
Gross Margin
59%
Country US
Market Cap 22.9B USD
Gross Margin
62%
Country US
Market Cap 22.3B USD
Gross Margin
35%

Profitability Report

View the profitability report to see the full profitability analysis for Windlas Biotech Ltd.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
37.4%
=
Gross Profit
2.5B
/
Revenue
6.6B
What is the Gross Margin of Windlas Biotech Ltd?

Based on Windlas Biotech Ltd's most recent financial statements, the company has Gross Margin of 37.4%.